Summit ivonescimab shows OS hazard ratio of 0.76 in lung cancer trial
Go back to Summit ivonescimab shows OS hazard ratio of 0.76 in lung cancer trial| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 13.68 -1.3 (8.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.98 | 52 Week High | $19.75 | |||
| Open | $13.72 | 52 Week Low | $4.26 | |||
| Day High | $14.42 | P/E | N/A | |||
| Day Low | $13.20 | EPS | $0.00 | |||
| Volume | 5,496,370 | |||||
